Cleveland Clinic providers available to CVS MinuteClinic patients through telehealth

A new partnership will connect Cleveland Clinic providers with CVS MinuteClinic customers in Ohio for online and mobile doctor visits through the American Well telehealth platform.

Cleveland Clinic already has built a variety of telehealth programs around American Well’s telehealth platform including its Express Care Online consumer offering. CVS MinuteClinic will offer American Well’s technology and services to provide telehealth to customers in Ohio, as well as West Virginia.

“Our long-term view of telehealth is that it’s not only a new, welcome service that we can offer our existing patients, but it’s a way for Cleveland Clinic to extend our reach and serve more people who need help. We believe that it is important to remove barriers to great care like time, travel and distance, and we’re making that possible through this partnership in Ohio,” Peter Rasmussen, MD, medical director of distance health, Cleveland Clinic, said in a release.

2015 American Well survey found that 70 percent of consumers said they prefer an online video visit to an in-office setting to obtain a common prescription.

“Telehealth further expands on our high-quality and convenient service to our customers. In fact, from our own research, we’ve found that 95 percent of patients were highly satisfied with the care they received, the ease with which telehealth technology was integrated into the visit, and the timeliness and convenience of their care. We are looking forward to explore new and innovative ways to improve access to patient care with American Well and Cleveland Clinic,” said Andrew Sussman, MD, executive vice president and associate chief medical officer, CVS Health and president, MinuteClinic.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.